Clinical Trial Update: Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing incidence of hypophosphatemia after treatment with iron isomaltoside/ferric derisomaltose versus ferric carboxymaltose in iron de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)
• Iron isomaltoside/ferric derisomaltose (ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2020-02-25